Clinical Trial Update: Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Angiotensin-(1-7) to improve cognitive functioning in patients with chronic heart failure is suspended. The study was sponsored by t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Heart Failure

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: University of Arizona | Conditions: Chronic Heart Failure, Cognitive Impairment | Phase 2 | Status: SUSPENDED